PARIS (dpa-AFX) - Sanofi (SNY, SNYNF.PK) and Bristol-Myers Squibb Co. (BMY) said Apotex has made payment in the amount of $442.21 million to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix patent infringement case against Apotex. This payment, following the decision of the U.S. Court of Appeals for the Federal Circuit in October 2011 upholding the payment of damages to the companies by Apotex, represents the final phase of the Plavix patent litigation between the companies and Apotex, which was initiated on March 21, 2002.
Sanofi and Bristol-Myers Squibb were also granted $1.26 million in post-judgment interest and $900,000 in costs in addition to the damages award, and both the companies are pleased that their intellectual property rights have been upheld and that Apotex has made reparation of the harm caused by the at-risk launch of a generic version of clopidogrel bisulfate in 2006.
Copyright RTT News/dpa-AFX
© 2012 AFX News
